Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Credit > Impending Credit Card Disaster: Don't Let Rising Interest Rates Catch You By Surprise

Tags

  • companies
  • point
  • could
  • benchmark federal
  • companies involved

  • Links

  • California Divorce and Child Custody: What is a Mediator?
  • Making Your Pages Look Good - How to Use The Right Typeface the Right Way
  • Stinkin' Thinkin'
  • Just Other Articles - Impending Credit Card Disaster: Don't Let Rising Interest Rates Catch You By Surprise

    For the past five years, interest rates have been lower than they have been in decades, with the benchmark federal funds rate bottoming out at a mere 1% and the prime rate hovering at just 4% for much of 2003 and
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    2004. As a result, many credit cards have been offering much lower interest rates to their customers. In fact, many consumers have grown accustomed to these lower rates. Many of these consumers are in for a r
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    de awakening.

    The problem is that most credit cards have variable interest rates. Often these rates are tied to the prime rate, so that for every point the prime rate rises, the credit card interest goes up a po
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    nt as well. This can lead to sharp increases in monthly payments for most credit card holders when the prime rate is on the rise.

    Since late 2004, the Fed has been continually raising the benchmark federal fund
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rate. As of June, 2006, that rate has risen to 5.25%, and it is expected to be raised at least another ? point when the Fed meets again in August. That would mean that anyone with a credit card tied to the pri
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    e rate would have seen a 4 ?% increase in their interest rate over the span of some 18 months. This escalation in interest rates can have a devastating effect on a consumer’s monthly budget.

    For example, take a
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    onsumer carrying who is $9000 in credit card debt, which, incidentally, is the amount of such debt carried by the average American consumer. Let’s assume this consumer had been enjoying a relatively low 9% inter
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    st rate on their credit card purchases from 2002-2005, when the prime rate was around 4%. By August of 2006, this interest rate would have risen to 13.5%, a very significant increase indeed.

    That 4.5% increase
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    n this customer’s interest rate could lead to an increase of $405 a month or more in his or her monthly credit card payment, and that is assuming no new charges are made. An additional $405 is quite a monthly hi
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    . In fact, many consumers are simply unable to handle such an increase. So what can be done to avert financial disaster?

    One possibility would be to move the balance of the debt to a fixed rate loan. This cou
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    d include taking out a home equity loan or even a personal line of credit. With regards to home equity loans, it is important to take into consideration that, while such loans often offer a significantly lower i
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    nterest rate than credit cards, this reduction comes because such loans are secured. You are, in effect, putting your home up as collateral. Credit cards are usually unsecured loans. If you miss a payment, you
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    personal property cannot automatically be repossessed.

    Personal lines of credit are another potential means of consolidating debts under a fixed interest rate. Often, consolidation loans are not secured, much
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ike credit cards. However, because of this they tend to have higher interest rates than home equity loans. Nonetheless, for some consumers, consolidating higher interest credit card debt with personal line of c
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    edit can be a viable means of reducing interest and lowering monthly payments. It is important to read the fine print with such a loan. Make sure the loan truly has a fixed rate. Whether or not this method wil
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    work for you depends on several factors, including your credit score. If your score is on the low side, then the interest rate and other terms of a personal loan might not be acceptable.

    So what if neither a h
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    me equity loan nor a personal line of credit is the answer for you? The first thing to do is simple: stop spending. You must stop adding new credit card debt immediately and start paying down your curre
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    t principal by increasing your monthly payments as much as you can. Think of ways you can cut back on your spending. For instance, go to one less movie a month and apply the twenty bucks to your credit card. O
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    you could make your morning coffee at home instead of buying it at at your favorite coffee house, then take the $3.50 a day you save and use it to pay down your credit card bill. Do whatever it takes.

    With inf
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ation threatening to increase, the Fed might well be forced to increase rates even further. So, pay off as much of your debt as you can now, before the variable interest rates come back to bite you in the future


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/91572/justotherarticles-Impending-Credit-Card-Disaster-Dont-Let-Rising-Interest-Rates-Catch-You-By-Surprise.html">Impending Credit Card Disaster: Don't Let Rising Interest Rates Catch You By Surprise</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/91572/justotherarticles-Impending-Credit-Card-Disaster-Dont-Let-Rising-Interest-Rates-Catch-You-By-Surprise.html]Impending Credit Card Disaster: Don't Let Rising Interest Rates Catch You By Surprise[/url]

    Related Articles:

    Listen To Network Marketing Failures To Create Your MLM Marketing Success

    Business Cards : Does Your Business Information Stick?

    What Information Should You Store In Your Customer Database - And Why?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com